Aclaris Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2016 to Q2 2024.
  • Aclaris Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -31.3 %, a 26.7% increase year-over-year.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2023 was -40.2 %, a 18.6% decline from 2022.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2022 was -33.9 %, a 10.2% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Return On Assets for 2021 was -37.7 %, a 40.1% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -31.3 +11.4 +26.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.4 -0.05 -0.13% Jan 1, 2024 Mar 31, 2024
Q4 2023 -40.2 -6.31 -18.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -48.9 -16.8 -52.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -42.7 -9.98 -30.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -37.4 -5.95 -18.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -33.9 +3.84 +10.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.1 +9.38 +22.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.7 +15.1 +31.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.4 +34.5 +52.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -37.7 +25.2 +40.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -41.5 +22.7 +35.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -47.8 +44 +47.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -66 +31.4 +32.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -62.9 +25.6 +29% Oct 1, 2020 Dec 31, 2020
Q3 2020 -64.1 +15.9 +19.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -91.8 -22.9 -33.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -97.3 -35.5 -57.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -88.5 -27.8 -45.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -80 -24.4 -43.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -68.9 -24.6 -55.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -61.8 -23.6 -61.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -60.7 -28.4 -87.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -55.6 -26.4 -90.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -44.2 -11.5 -35% Apr 1, 2018 Jun 30, 2018
Q1 2018 -38.2 -1.91 -5.26% Jan 1, 2018 Mar 31, 2018
Q4 2017 -32.3 +10.8 +25.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -29.3 +16.2 +35.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -32.8 +18.9 +36.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -36.3 Jan 1, 2017 Mar 31, 2017
Q4 2016 -43.2 Oct 1, 2016 Dec 31, 2016
Q3 2016 -45.5 Jul 1, 2016 Sep 30, 2016
Q2 2016 -51.7 Apr 1, 2016 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.